Cargando…

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of malignant tumours that affects over 500,000 patients per year. Treatment failure is generally due to the heterogeneity of these tumours and to the serious adverse effects associated with treatment. Immunological system impairm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaszczak, Wiktoria, Barczak, Wojciech, Wegner, Anna, Golusinski, Wojciech, Suchorska, Wiktoria Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357244/ https://www.ncbi.nlm.nih.gov/pubmed/28315228 http://dx.doi.org/10.1007/s12032-017-0918-1

Ejemplares similares

Fucoidan Exerts Anticancer Effects Against Head and Neck Squamous Cell Carcinoma In Vitro
por: Blaszczak, Wiktoria, et al.
Publicado: (2018)

Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review
por: Dylawerska, Agata, et al.
Publicado: (2017)

The importance of stem cell engineering in head and neck oncology
por: Barczak, Wojciech, et al.
Publicado: (2016)

RNA interference in head and neck oncology
por: Sobecka, Agnieszka, et al.
Publicado: (2016)

Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape
por: Romanowska, Kamila, et al.
Publicado: (2020)

hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification
por: Barczak, Wojciech, et al.
Publicado: (2018)

Tissue and serum microRNA profile of oral squamous cell carcinoma patients
por: Schneider, Augusto, et al.
Publicado: (2018)

The m(6)A RNA Modification Quantity and mRNA Expression Level of RNA Methylation-Related Genes in Head and Neck Squamous Cell Carcinoma Cell Lines and Patients
por: Romanowska, Kamila, et al.
Publicado: (2021)

The Kinetics of γ-H2AX During Radiotherapy of Head and Neck Cancer Potentially Allow for Prediction of Severe Mucositis
por: Kazmierska, Joanna, et al.
Publicado: (2020)

Universal Real-Time PCR-Based Assay for Lentiviral Titration
por: Barczak, Wojciech, et al.
Publicado: (2014)

miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients
por: Piotrowski, Igor, et al.
Publicado: (2021)

Vitamin C as a Modulator of the Response to Cancer Therapy
por: Blaszczak, Wiktoria, et al.
Publicado: (2019)

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells
por: Allen, Brittany, et al.
Publicado: (2018)

Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma
por: Szewczyk, Mateusz, et al.
Publicado: (2014)

Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence
por: Zhi, Xu, et al.
Publicado: (2014)

Immune modulation underpins the anti‐cancer activity of HDAC inhibitors
por: Blaszczak, Wiktoria, et al.
Publicado: (2021)

The Use of Photodynamic Therapy for Head, Neck, and Brain Diseases
por: Domka, Wojciech, et al.
Publicado: (2023)

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond
por: Golusiński, Wojciech
Publicado: (2019)

Outdoor work as a risk factor for high-grade cutaneous squamous cell carcinoma of the head and neck
por: Szewczyk, Mateusz, et al.
Publicado: (2018)

Challenges in organizing effective oncology service: inter-European variability in the example of head and neck cancers
por: Malicki, Julian, et al.
Publicado: (2014)

Circulating small non coding RNA signature in head and neck squamous cell carcinoma
por: Martinez, Berta Victoria, et al.
Publicado: (2015)

Current indications and patient selection for transoral robotic surgery in head and neck cancer – a brief review
por: Niewinski, Patryk, et al.
Publicado: (2022)

Autoregulation of H(+)/lactate efflux prevents monocarboxylate transport (MCT) inhibitors from reducing glycolytic lactic acid production
por: Blaszczak, Wiktoria, et al.
Publicado: (2022)

Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT
por: Peszynska-Piorun, Magdalena, et al.
Publicado: (2012)

Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma
por: Szewczyk, Mateusz P., et al.
Publicado: (2014)

The impact of the COVID-19 pandemic on the management of head and neck cancer patients at a tertiary care institution in Poland
por: Szewczyk, Mateusz, et al.
Publicado: (2021)

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
por: Vatte, Chittibabu, et al.
Publicado: (2017)

Polydopamine-Based Material and Their Potential in Head and Neck Cancer Therapy—Current State of Knowledge
por: Witkowska, Marta, et al.
Publicado: (2023)

What do cellular responses to acidity tell us about cancer?
por: Blaszczak, Wiktoria, et al.
Publicado: (2021)

Permeability and driving force: why is it difficult to control glycolytic flux by blocking lactate transporters?
por: Blaszczak, Wiktoria, et al.
Publicado: (2023)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
por: Lüttich, Lina, et al.
Publicado: (2021)

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
por: Beloueche-Babari, M, et al.
Publicado: (2015)

Sequential delayed [18 F]FDG PET/CT examinations in the pharynx
por: Pietrzak, Agata Karolina, et al.
Publicado: (2020)

The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
por: Russell, Jeffery S., et al.
Publicado: (2012)

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management
por: Abdullah, Shaad E., et al.
Publicado: (2012)

Management of clinically negative neck in salivary gland cancers – elective neck dissection, irradiation, or surveillance?
por: Szewczyk, Mateusz, et al.
Publicado: (2019)

The concept of radiation-enhanced stem cell differentiation
por: Mieloch, Adam A., et al.
Publicado: (2015)

Interplay between inflammation and cancer
por: Piotrowski, Igor, et al.
Publicado: (2020)

Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature
por: Majchrzak, Ewa, et al.
Publicado: (2014)

Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oni7av2pnuru2bdm6ih337d5tn